This Week Last Year in Medtech: Oct. 30 – Nov. 5

Abiomed Struggles with Delta Variant and Hospital Labor Shortages

The Danvers, MA-based company trimmed FY22 outlook by $20 million.

Stryker Struck by Q3 Double Whammy: Delta and Hospital Staffing Shortages

Companies across the medical device industry were impacted by a common double whammy in the third quarter, and Stryker was not immune.

Boston Sci Scores Critical Win in Patent Dispute with Nevro

A Delaware jury has ordered Nevro to pay Boston Scientific $20 million regarding the infringement of two patents for spinal cord stimulation technology.

COVID-19 Diagnostics Still Play a Huge Role in Hologic’s Earnings

The Waltham, MA-based was able to beat consensus. Will its success herald even more M&A.

Is the New CMS Ruling a Win for iRhythm?

Will this fee decision benefit the San Francisco, CA-based company in the long run?

Is Integra's Breast Reconstruction PMA Doomed?

Despite getting shot down by a recent FDA advisory panel, Integra's management team still seems confident that the agency will ultimately approve SurgiMend for post-mastectomy breast reconstruction.

Measuring the Influence of FDA Advisory Committee Recommendations on Approval Decisions

The agency tends to agree with advisory committee recommendations, but not always.